It has been reported that CD93 has a role in the self-renewal and proliferation of the CML LSCs and CD93 expressing LSCs showed resistance to TKIs [73,74]. The gene discussed is CD93; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.